UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice

J Hepatol. 2020 Sep;73(3):499-501. doi: 10.1016/j.jhep.2020.04.040. Epub 2020 Jun 20.

Authors

Jessica K Dyson¹, David E J Jones²

Affiliations

¹ Translational and Clinical Research Institute, Newcastle University & Liver Unit, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
² Translational and Clinical Research Institute, Newcastle University & Liver Unit, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK. Electronic address: David.Jones@ncl.ac.uk.

PMID: 32576471
DOI: 10.1016/j.jhep.2020.04.040

No abstract available

Keywords: Cholestasis; Disease recurrence; Prevention; Primary biliary cholangitis; Transplantation.

Publication types

Editorial
Comment

MeSH terms

Cholagogues and Choleretics / therapeutic use
Humans
Liver Cirrhosis, Biliary* / drug therapy
Recurrence
Ursodeoxycholic Acid / therapeutic use

Substances

Cholagogues and Choleretics
Ursodeoxycholic Acid

Grants and funding

MR/L001489/1/MRC_/Medical Research Council/United Kingdom